Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Nonseminomatous germ cell tumor × dabrafenib × 1 year × Clear all

Sponsor

Conditions

Melanoma 16 Glioma 6 Thyroid Carcinoma, Anaplastic 5 Carcinoma, Non-Small-Cell Lung 5 Thyroid Neoplasms 4 Neoplasms 4 Neoplasm Metastasis 4 Multiple Myeloma 4 Colorectal Neoplasms 3 Thyroid Cancer, Papillary 2 Skin Neoplasms 2 Histiocytosis, Langerhans-Cell 2 Hematologic Neoplasms 2 Glioblastoma 2 Fever 2 Brain Neoplasms 2 Astrocytoma 2 Thyroid cancer, follicular 1 Thyroid cancer, Hurthle cell 1 Sarcoma 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Rare Malignant Neoplasm 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neurocytoma 1 Neuroblastoma 1

Interventions

Drug Therapy 2 tremelimumab 1 fludarabine phosphate 1 fludarabine 1 durvalumab 1 cabozantinib 1 Etoposide 1 Cyclophosphamide 1 BEP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡